<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7102570\results\search\virus\results.xml">
  <result pre="al., 2016). We observed a transition of influenza virus and" exact="poliovirus" post="in cultures treated with favipiravir but did not assess"/>
  <result pre="incorporated site during the elongation of herpes simplex virus and" exact="varicella-zoster virus" post="DNA and prevents viral DNA synthesis. However, the incorporated"/>
  <result pre="are guanosine analogues, function as an anti-herpes simplex virus and" exact="varicella-zoster virus" post="agent and anti-cytomegalovirus agent, respectively, with mechanisms similar to"/>
  <result pre="simplex virus resistant to acyclovir, phosphonoacetic acid, and foscarnet, a" exact="varicella-zoster virus" post="resistant to acyclovir, penciclovir, foscarnet, and vidarabine, and a"/>
  <result pre="with favipiravir We tried to isolate favipiravir-resistant influenza virus and" exact="poliovirus" post="from 28 and 10 25Â cm2 flasks, respectively, after"/>
  <result pre="Spontaneous mutation rates of the influenza virus RdRp complex and" exact="poliovirus" post="3D RdRp are both approximately 1Â Ã—Â 10âˆ’4 (Cheung"/>
  <result pre="1993; Gubareva &amp;amp; Fry, 2019). Titers of influenza virus and" exact="poliovirus" post="in the culture reach approximately 108 infectious viral particles/mL"/>
  <result pre="favipiravir-resistant mutants. We isolated susceptibility variants of influenza virus and" exact="poliovirus" post="in the cultures treated with favipiravir for a month"/>
  <result pre="Recently, mutants of influenza virus (Goldhill et al., 2018) and" exact="chikungunya virus" post="(Abdelnabi et al., 2017; Delang et al., 2014) that"/>
  <result pre="mutation in the F1 motif of the RdRp (nsP4) in" exact="chikungunya virus" post="is less susceptible to favipiravir, displays a reduced growth"/>
  <result pre="et al., 2014). The corresponding K-to-R substitution (K159R) of the" exact="chikungunya virus" post="K291R mutation was introduced in the coxsackievirus B3 RdRp,"/>
  <result pre="of the chikungunya virus K291R mutation was introduced in the" exact="coxsackievirus" post="B3 RdRp, but the engineered virus with the K159R"/>
  <result pre="placebo-controlled trial. As an example of this situation, PEP of" exact="human immunodeficiency virus" post="has been performed to protect against needle sticks or"/>
  <result pre="sent to the institution. References References AbdelnabiR.JochmansD.VerbekenE.NeytsJ.DelangL.Antiviral treatment efficiently inhibits" exact="chikungunya virus" post="infection in the joints of mice during the acute"/>
  <result pre="phosphoribosyltransferasesThe Journal of Biological Chemistry2752000202312023410816600 DaikokuT.MizuguchiM.ObitaT.YokoyamaT.YoshidaY.TakemotoM.ShirakiK.Characterization of susceptibility variants of" exact="poliovirus" post="grown in the presence of favipiravirJournal of Microbiology, Immunology,"/>
  <result pre="and emerging RNA virusesAntiviral Research1532018859429524445 DelangL.Segura GuerreroN.TasA.QueratG.PastorinoB.FroeyenM. â€¦LeyssenP.Mutations in the" exact="chikungunya virus" post="non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum"/>
  <result pre="Science232000637210699766 IdaM.KageyamaS.SatoH.KamiyamaT.YamamuraJ.KurokawaM. â€¦ShirakiK.Emergence of resistance to acyclovir and penciclovir in" exact="varicella-zoster virus" post="and genetic analysis of acyclovir-resistant variantsAntiviral Research40199915516610027650 JacobsM.AaronsE.BhaganiS.BuchananR.CropleyI.HopkinsS. â€¦RodgerA.Post-exposure"/>
  <result pre="and Chemotherapy6020164620462927185803 JulanderJ.G.ShaferK.SmeeD.F.MorreyJ.D.FurutaY.Activity of T-705 in a hamster model of" exact="yellow fever virus" post="infection in comparison with that of a chemically related"/>
  <result pre="compound, T-1106Antimicrobial Agents and Chemotherapy53200920220918955536 JulanderJ.G.SmeeD.F.MorreyJ.D.FurutaY.Effect of T-705 treatment on" exact="western equine encephalitis" post="in a mouse modelAntiviral Research82200916917119428608 KamiyamaT.KurokawaM.ShirakiK.Characterization of the DNA"/>
  <result pre="health service guidelines for the management of occupational exposures to" exact="human immunodeficiency virus" post="and recommendations for postexposure prophylaxisInfection Control and Hospital Epidemiology34201387589223917901"/>
  <result pre="in Experimental Medicine and Biology1045201810312229896665 ShirakiK.OginoT.YamanishiK.TakahashiM.Isolation of drug-resistant mutants of" exact="varicella-zoster virus" post="- cross resistance of acyclovir resistant mutants with phosphonoacetic"/>
  <result pre="TalaricoC.L.PhelpsW.C.BironK.K.Analysis of the thymidine kinase genes from acyclovir-resistant mutants of" exact="varicella-zoster virus" post="isolated from patients with AIDSJournal of Virology671993102410338380452 TanakaT.KamiyamaT.DaikokuT.TakahashiK.NomuraN.KurokawaM.ShirakiK.T-705 (Favipiravir)"/>
 </snippets>
</snippetsTree>
